According to CBinsights data, the Novo Group tops the list of the most active corporate investors in the healthcare sector in terms of level of investment and number of deals. Johnson & Johnson and Novartis complete the top three.
1TP2Q1.81B of investment up 241TP1Q from previous quarter
Investment and exits in the healthcare sector made a strong comeback during 2Q13. Not only did capital invested and funded in healthcare companies reach 1.81B$ (up 24% from 1Q13) but investment in early stage companies also grew to the 5th highest quarter. In addition, IPO deals sweetened a moribund market with 11 VC-funded companies taken to IPO during 2Q13.
"Also in Spain we have seen significant sales of companies such as Endosense of the Ysios fund. We are optimistic for the sector because much of the money from these sales will return to the health sector financing circuit as SODENA has stated today," says Diego Gutierrez corporate finance expert at ABRA INVEST." In fact, the health sector is second only to the ICT sector, both in Spain and in the United States," says Diego Gutierrez.
Top 3: Novo Group, Johnson & Johnson and Novartis
Based on levels of M&A activity, the Denmark-based Novo Group tops the list with more than 50 investments made in health-related companies. Just behind the Novo Group are Swiss-based pharmaceutical giants Johnson & Johnson and Novartis, both of which maintain their private equity arms.
Pharmaceutical companies among the top 10 most active corporate investors across all sectors
Johnson & Johnson Development Corp. and Novartis Venture Funds, are ranked among the top 10 most active investors as "Corporate Venture Capital"across all sectors. Eight of the 10 are companies listed on the New York Stock Exchange. "Ventura corporate capital is resurfacing as it did in the dotcom era. The trend looks set to continue in Q2 2013 with a 40% growth in the number of CVCs involved in a transaction," says Diego Gutierrez.
EN 
ES